Rheumnow Podcast

Hiring, Onboarding and Training APPs

Watch our kickoff webinar for this month's Mission: APP — Partners in Care campaign. Our panel of rheumatologists and experienced advanced practice providers share insights into hiring, onboarding, training, compensation, and more.

Panelists:
Philip Mease, MD
Cayla Alexander, DNP, ARNP
Kori Dewing, DNP, ANP-BC, ARNP
Jack Cush, MD, Moderator

Turkey Tryptophan (11.28.2025)

Dr. Jack Cush reviews the news and reports from this past week on RheumNow.com, including reports on FDA resurrections, FM seasonal worsening, and do you fight switch or swap biologics in PsA TNFi nonresponders?

DERM on RheumNow (November 2025)

The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects.
 Features Dr. Jack Cush, Editor at RheumNow.com. 
SHOW NOTES
1. Retrospective study of 39 pts w/ MDA5 + DM-ILD Rx w baricitinib. 31 (79.5%) had improvement in Gottron’s, heliotrope, dyspnea, HRCT score, ferritin, LDH, steroid dose & 6 mo survival (87% vs. 70%, p = 0.047). https://t.co/RCTbBsCkeV
2. Pulse Steroids and Mycophenolate in Juvenile Dermatomyositis JAMA Dermatology has published a pilot study demonstrating the safety and efficacy of intermittent intravenous methylprednisolone pulse (IVMP) therapy plus mycophenolate in 28 patients with JDM. https://t.co/i2HBycbWY9
3. Myelodysplastic & chr myelomonocytic leukemia pts rarely get lupus. Review of 19 w/ SLE & 5 w/ CLE; these were older (65 yrs), more male (15M/9F), w/ less renal [10%] & articular [36%] Dz w/ less dsDNA [32%]. Thought to be clonal inflammatory, & not autoinflammatory, process. https://t.co/EAvkJm6GQs
4. Serious infections w/ adalimumab. Marketscan MarketScan claims study (1/17-12/20) of ADA Rx in Hidradenitis Supprativa (n 1650) or psoriasis(8699). Risk of SIE & hospitalization greater w/ HS (HR 1.53); esp for sepsis & GU infxnhttps://t.co/2qa7O2v6fm
5. No risk of MACE seen w/ initiation of IL-17(R)A inhib. French study of 34 241 ipts Rx IL-17(R)Ai and 381 MACEs. MACE risk was not elevated (OR, 1.25 [95% CI, 0.75-2.08] vs TNF-α inhibitors. https://t.co/WcjgRhr8mj
6. Genetic Risks and Severe Cutaneous Reactions to Allopurinol A matched cohort study shows that HLA-B*58:01 and HLA-A*34:02 are strongly associated with allopurinol-induced severe cutaneous adverse reactions (SCARs), these alleles were absent in more than one-third of those https://t.co/NLpHVhr9Ww
7. Western Australia study of 1854 SLE pts (median 40 yrs old). Interstitial lung disease was seen in in 3.8% of SLE, 26 fold more than controls. Risk factors for ILD included older age, smoking and serositis. SLE-ILD pts had higher mortality rates (MR 52.0, CI 37.0–71.1).
8. 25-Hydroxyvitamin D levels and Lupus Outcomes Lupus patients entering a prospective cohort study with low vitamin D levels faced doubled all-cause mortality risk and tripled risk for major cardiovascular events during follow-up averaging 6 years, researchers said. https://t.co/CYwVy7ls7y
9. ACR2025 Non-Renal Lupus Guidelines – from ACR Convergence 2025
10. 900,000 vs 9 It takes about 900,000 minutes to become a board-certified dermatologist. At that point, you might be very skilled and well-informed. It takes less than nine minutes to make your patient feel seen, understood and reassured. If you skip the 9 minutes, you wasted the 900,000  https://t.co/o7BaWjS4HB

Tuesday Nite Rheumatology (on 11.25.25)

Replay of RheumNow Live 2025 - Vasculitis
Featuring: 

- Dr. Michael Wechsler: Management of EGPA in 2025
- Dr. Rennie Rhee: Imaging in Vasculitis
- Dr. Richard Conway: Modern Treatment of PMR

Vitamin D and Lupus Outcomes (11.21.2025)

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.

Check out: 
RNL 2026 – Feb 7 8 2026 DFW
RheumNow.live

Tuesday Nite Rheumatology (on 11.18.25)

Replay of RheumNow Live 2025 - Spondyloarthritis
Sponsored by AbbVie

Featuring: 
Dr. Desiree van der Heidje - Advances in Treatment of Spondyloarthritis  
Dr. Jennifer Cather - Progress in Hidradenitis Supprativa
Dr. Catherine Bakewell - Imaging Evaluation of Spondyloarthritis

Treating During Pregnancy (11.14.2025)

TNR 11.11.2025 - Replay of RheumNow Live 2025 - Psoriatic Arthritis

Replay of RheumNow Live 2025 - Psoriatic Arthritis
Sponsored by AbbVie

Featuring: 
Dr. Alexis Ogdie - Can Aggressive Treatment of Psoriasis Prevent PsA?
Dr. Artie Kavanaugh - Combination Biologic Therapies in PsA
Dr. Kenneth Gordon - Head-to-head Studies in Psoriatic Disease – What have we learned?

TNR 11.6.2025 - Replay of RheumNow Live 2025 - Rheumatoid Arthritis

Featuring: 
Dr. Jeffrey Curtis:  AI applied to Rheumatoid Arthritis Care: Practically (Not) Perfect 
Dr. Una Makris:  Key Considerations When Managing Older Adults with RA
Dr. Bryant England: Who will manage multimorbidity in RA

A JAKi in GCA- Phase 3 Results Through 2 Years

A JAKi in GCA- Phase 3 Results Through 2 Years
Sponsored by AbbVie Medical Affairs + Health Impact